Covered recipient · General Payments record
ALYSSA JENKINS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$3,061.26
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.61 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.40 | 10 |
| Axsome Therapeutics, Inc. | $82.02 | 4 |
| INTUITIVE SURGICAL, INC. | $35.77 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.28 | 1 |
| SHIELD THERAPEUTICS INC | $18.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.27 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400020 | CMS |
| ABBVIE INC. | $29.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400022 | CMS |
| ABBVIE INC. | $10.17 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400024 | CMS |
| ABBVIE INC. | $11.95 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400026 | CMS |
| ABBVIE INC. | $19.74 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400028 | CMS |
| ABBVIE INC. | $21.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400030 | CMS |
| ABBVIE INC. | $19.83 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400032 | CMS |
| ABBVIE INC. | $16.03 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400034 | CMS |
| ABBVIE INC. | $5.30 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400036 | CMS |
| ABBVIE INC. | $16.47 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400038 | CMS |
| Axsome Therapeutics, Inc. | $18.96 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148332229 | CMS |
| Axsome Therapeutics, Inc. | $28.49 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148332233 | CMS |
| Axsome Therapeutics, Inc. | $19.30 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148332231 | CMS |
| Axsome Therapeutics, Inc. | $15.27 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148332235 | CMS |
| Boston Scientific Corporation | $18.28 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092656250 | CMS |
| INTUITIVE SURGICAL, INC. | $35.77 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137288377 | CMS |
| SHIELD THERAPEUTICS INC | $18.14 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116357 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.